These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17827508)

  • 1. Secrets of success in unprotected left main intervention: patient and lesion selection.
    Sharma M; Yeghiazarians Y
    J Invasive Cardiol; 2007 Sep; 19(9):388-9. PubMed ID: 17827508
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of restenosis in drug-eluting stents: still a challenge!
    Gupta M; Kadakia J; Budoff MJ
    J Invasive Cardiol; 2010 May; 22(5):220-1. PubMed ID: 20440038
    [No Abstract]   [Full Text] [Related]  

  • 3. For which patients with left main stem disease is percutaneous intervention rather than coronary artery bypass grafting the better option?
    Malvindi PG; Dunning J; Vitale N
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):306-14. PubMed ID: 18194978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
    Meliga E; Valgimigli M; Buszman P; Serruys PW
    J Am Coll Cardiol; 2008 Aug; 52(7):582-4; author reply 584-6. PubMed ID: 18687257
    [No Abstract]   [Full Text] [Related]  

  • 5. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease.
    Schrale RG; van Gaal W; Channon KM; Forfar JC; Ormerod OJ; Banning AP
    Int J Cardiol; 2008 Nov; 130(2):185-9. PubMed ID: 18083253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease.
    Kitamura S; Tsuda E; Kobayashi J; Nakajima H; Yoshikawa Y; Yagihara T; Kada A
    Circulation; 2009 Jul; 120(1):60-8. PubMed ID: 19546384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.
    Taggart D
    J Am Coll Cardiol; 2008 Nov; 52(20):1680-1; author reply 1681. PubMed ID: 18992662
    [No Abstract]   [Full Text] [Related]  

  • 10. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiology patient page. Drug-eluting stents.
    Maisel WH; Laskey WK
    Circulation; 2007 May; 115(17):e426-7. PubMed ID: 17470700
    [No Abstract]   [Full Text] [Related]  

  • 12. How appropriate for assessing quality are the 2009 Appropriateness Criteria for Coronary Revascularization?
    Klein LW
    J Invasive Cardiol; 2009 Nov; 21(11):558-62. PubMed ID: 19901408
    [No Abstract]   [Full Text] [Related]  

  • 13. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
    Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Cook S; Reardon L; Moretti C; De Servi S; Palacios IF; Windecker S; Colombo A; van Domburg R; Sheiban I; Serruys PW;
    J Am Coll Cardiol; 2008 Jun; 51(23):2212-9. PubMed ID: 18534266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous stenting versus bypass surgery for unprotected left main coronary artery disease.
    Takagi H; Manabe H; Umemoto T
    Am J Cardiol; 2010 Oct; 106(7):1059. PubMed ID: 20854975
    [No Abstract]   [Full Text] [Related]  

  • 15. Percutaneous coronary intervention versus coronary-artery bypass grafting.
    Bhindi R; Figtree GA
    N Engl J Med; 2009 Jun; 360(25):2672; author reply 2674-5. PubMed ID: 19535807
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplasty.
    Vignali L; Talanas G; Menozzi A; Cattabiani MA; Solinas E; Aurier E; Ardissino D
    Minerva Cardioangiol; 2008 Feb; 56(1):1-11. PubMed ID: 18432163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention, diabetes mellitus, and death.
    Dauerman HL
    J Am Coll Cardiol; 2010 Mar; 55(11):1076-9. PubMed ID: 20079595
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary stenting challenges: technique, design and pharmacology.
    Linnemeier TJ
    J Invasive Cardiol; 1999 Jan; 11(1):43-6; discussion 46. PubMed ID: 10745437
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound?
    Taggart DP
    Curr Opin Cardiol; 2007 Nov; 22(6):517-23. PubMed ID: 17921738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.